CLINICAL_TRIALS
trial_result
· 2018-10-23
Clinical Trial Update: GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL. [Phase 2]
Summary
Phase 2 clinical trial evaluating high-dose anthracycline added to induction therapy for adults with acute lymphoblastic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: UNKNOWN